Treatment patterns and clinical outcomes in stage III non-small-cell lung cancer: a long-term institutional experience in Switzerland
Almost 90% of patients with stage III NSCLC underwent treatment with curative intent, with rates of treatment adherence that compared favourably to the literature. Although survival outcomes appear to have improved in recent years, the rates of disease recurrence remain high, reflecting a need for further improvements.
Authors
- Kathleen Jahn (ORCID: https://orcid.org/0000-0002-6216-1024)
- Sacha I. Rothschild (ORCID: https://orcid.org/0000-0003-1304-9340)
- Tobias Finazzi (ORCID: https://orcid.org/0000-0002-4118-4171)
- Spasenija Savic Prince (ORCID: https://orcid.org/0000-0002-4065-5111)
- David König (ORCID: https://orcid.org/0000-0003-3559-6855)
- Didier Lardinois (ORCID: https://orcid.org/0009-0002-8285-8360)
- Jens Bremerich (ORCID: https://orcid.org/0000-0002-1002-8483)
- Judith Hafer
- Ali Turunç (ORCID: https://orcid.org/0000-0003-1317-4969)
Institutions
- University Hospital of Basel (CH)
- Kantonsspital Baden (CH)
Publication Details
- Journal
- Swiss Medical Weekly
- Published
- 2025-09-22
- DOI
- https://doi.org/10.57187/s.4522
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00